Do you want to read an article? Please log in or register.
Insights from a 10-year Australasian idiopathic hypersomnia patient data registry study
Sleep Apnea
RECOMMENDED
Related content
Pulmonary Fibrosis
LONGITUDE: An observational study of the long-term effectiveness of elexacaftor/tezacaftor/ivacaftor in people aged ≥12 years with cystic fibrosis using data from the United Kingdom Cystic Fibrosis Registry - 2-year analysis
J Cyst Fibros
Vega-Hernandez G, MacGregor G, Wilfin A, Adams F, Haugh C, Baxter CA, Wöhling H, Clarke SL, Charman SC, Carr SB
doi: 10.1016/j.jcf.2025.04.012
Pulmonary Fibrosis
Antifibrotic drug treatment of patients with idiopathic pulmonary fibrosis in Sweden: A registry-based observational study
Chron Respir Dis
Carlson L, Kalafatis D, Pesonen I, Magnusson JM, Skold M
doi: 10.1177/14799731241299443
Bronchi
Aspergillus serology and clinical outcomes in patients with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Chest
Pollock J, Goeminne PC, Aliberti S, Polverino E, Crichton ML, Ringshausen FC, Dhar R, Vendrell M, Burgel PR, Haworth CS, De Soyza A, De Gracia J, Bossios A, Rademacher J, Grünewaldt A, McDonnell M, Stolz D, Sibila O, van der Eerden M, Kauppi P, Hill AT, Wilson R, Amorim A, Munteanu O, Menendez R, Torres A, Welte T, Blasi F, Boersma W, Elborn JS, Shteinberg M, Dimakou K, Chalmers JD, Loebinger MR, EMBARC registry investigators
doi: 10.1016/j.chest.2024.06.3843
RECOMMENDED
Pulmonary Fibrosis
Lung Function Course of Patients With Pulmonary Fibrosis After Initiation of Anti-Fibrotic Treatment: Real-World Data From the Dutch National Registry
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respirology
Platenburg MGJP, Nakshbandi G, Moor CC, van Batenburg AA, Mostard RLM, Voortman M, Moonen L, Hekelaar N, Overbeek MJ, Bogaarts B, Kramer H, Marges E, Boerrigter BB, Bresser P, Schakenraad E, van der Maten J, van der Sloot CA, Walen S, Afonso PM, Wijsenbeek MS, Grutters JC
doi: 10.1111/resp.70030
Pulmonary Fibrosis
Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation
Lancet Respir Med
Alonso-González A, Jáspez D, Lorenzo-Salazar JM, Ma SF, Strickland E, Mychaleckyj J, Kim JS, Huang Y, Adegunsoye A, Oldham JM, Stewart I, Molyneaux PL, Maher TM, Wain LV, Allen RJ, Gisli Jenkins R, Kropski JA, Yaspan B, Blackwell TS, Zhang D, Garcia CK, Martinez FJ, Noth I, Flores C
doi: 10.1016/S2213-2600(25)00045-1
Further Publications
Prognostic significance of pleural fluid microbiological positivity in pleural infection: a bicentric 10-year retrospective observational study
Respir Res
Wong C, Fan HC, Rahman NM, Wong JCC, Cheng HS, Chiu PH, Tong CW, Miu FPL, Yam LYC
doi: 10.1186/s12931-025-03129-5
Asthma
Costs of Oral Corticosteroid Use in Patients with Severe Asthma With/Without Chronic Rhinosinusitis with Nasal Polyps: Data from the Italian SANI Registry
Adv Ther
Heffler E, Blasi F, Paggiaro P, Canonica GW
doi: 10.1007/s12325-024-03071-w
Pulmonary Fibrosis
Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry
Ann Am Thorac Soc
Sack C, Wojdyla DM, MacMurdo MG, Gassett A, Kaufman JD, Raghu G, Redlich CA, Li P, Olson AL, Leonard TB, Todd JL, Neely ML, Snyder LD, Gulati M
doi: 10.1513/AnnalsATS.202404-382OC
Asthma
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up
Respir Med
Pini L, Caminati M, Maule M, Bagnasco D, Beghè B, Bondi B, Braido F, Cameli P, Caruso C, Crimi C, El Masri Y, Giordani J, Guarnieri G, Latorre M, Mastrototaro A, Menzella F, Micheletto C, Pini A, Piras S, Spanevello A, Vianello A, Visca D, Zappa M, Zurlo M, Paggiaro P, Blasi F, Canonica GW, Senna G, Benoni R, SANI study group
doi: 10.1016/j.rmed.2025.108198